Sponsor:
University of Southern California
Code:
NCT07306338
Conditions
Hematopoietic and Lymphatic System Neoplasm
Malignant Solid Neoplasm
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Non-Interventional Study
Brief summary:
Conditions
Hematopoietic and Lymphatic System Neoplasm
Malignant Solid Neoplasm
Study ID
NCT07306338
Start date
Dec 15, 2025
Status verified date
Mar, 2026
Completion date
Jan 31, 2028
Anticipated
Primary completion date
Jan 31, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
10 participants
Anticipated
Arms
Observational
Interventions
Non-Interventional Study
Primary outcome measure
Locations
USC / Norris Comprehensive Cancer Center
Recruiting
Los Angeles, California, United States, 90033
Contacts
Principal Investigator:
Xiaoyue M. Guo
Sponsor
University of Southern California
Last update posted
Mar 27, 2026
Last verified
Mar, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of Southern California on 2026-03-27.